Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 13G is out

Thanks for that correction (4M/month). When I was playing with those numbers, I was wondering if it would come down to end of May.

However, it seems probable the next 10Q could wipe S&L clean. And, again, I strongly believe S&L can continue to sell, if for no other reasons than because of the trend (and a possible written agreement - a record of intent pre settlement) and because the SELLS would not be for personal gain (beyond that that would be otherwise realized - assuming a good 10Q). Now, if he were BUYING, he'd be in trouble (I hope!).

JMHOs,

SGE

Share
New Message
Please login to post a reply